Gland Pharma Q1 net surges 47% to ₹317 cr on higher revenue
Rising earning graph | Photo Credit: Getty Images Injectable-focussed generic drugmaker Gland Pharma reported consolidated net profit for June quarter rose 47% year-on-year (YoY) to ₹317 crore. It came on a 20% YoY increase in revenue from operations to ₹1,800.3 crore. On a sequential basis, net profit was 14% lower and revenue 3% higher. Growth…
Read More “Gland Pharma Q1 net surges 47% to ₹317 cr on higher revenue” »